Canada Markets close in 6 mins

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
228.69+4.69 (+2.09%)
As of 03:54PM EST. Market open.
Sign in to post a message.
  • K
    Kevin…
    the only reason AMgen had been down in the previous market conditions is because people were chasing bumble-momentum market conditions. That is over. Your Amgen money from a year-year and a half ago didn't lose(unless you sold) it was a matter of time when the banks would clean the clocks of the new traders with stimulus money betting on tech names growth at all cost and companies with no profits, just a story. I expect amgen to do at least another 15-20% this year from here.
  • C
    Chris
    What’s driving this up? Two Price target cuts and it closes up $2 ?! I’m not complaining just want to hear opinions. Thanks
  • s
    sarath
    Old but an informative article.
    AMGN stock has not gone anywhere for two years.
    It needs a new push.
    https://www.reddit.com/r/BCRX/comments/pdz1su/amgen_is_targeting_bcrx_for_acquisition/
  • A
    Austin
    Top Trades For January 2022 👀🔥📈 >>

    https://chart-analysis.tools/top-trade-idea
  • S
    Steve
    B of A cuts to neutral from buy, cuts price target to $255 from $285.
  • D
    Dave01245
    Go AMGEN!!
  • L
    Lee
    So got an email from yahoo for yahoo+ 12/31/2021 AMGN bearish target $200. Look at regular yahoo shows bullish target $240. So what gives?????????????? Are they purposely putting out false or misleading info, and charging for their real estimates
  • B
    Brent
    Hard to rationalize the recent run-up with no corresponding boost to estimated earnings. Sell.
  • S
    Steve
    Truist cuts price target from $266 to $255.
  • K
    Kevin…
    Morgan Stanley Mike Wilson "We're moving away from large cap growth to large cap defensive." That's Amgen btw
  • V
    VIPUL
    Next year belongs to Biotechs, AMGN is the king.
  • V
    VIPUL
    THOUSAND OAKS, Calif., Dec. 23, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference at 1:00 p.m. ET on Thursday, Jan. 6, 2022. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
  • Q
    Quincy
    Sell covered call for Feb $240 to hedge.
  • X
    XFrank
    Very undervalued, good buying opportunity
  • J
    John
    This must be that "dead cat bounce" Stukin was referring to :-)
  • V
    VIPUL
    Biogen has started the run up for 2022. AMGN may be the best Dow stock in 2022. Long and strong and patient and collecting almost $8 in dividend while I wait.
  • L
    Len
    A great buying opportunity!
  • A
    Anonymous
    Pharma avoids big price cuts and can continue to fund research! All these stocks should be soaring.
  • L
    Len
    A great stock to own forever and three days!
  • Q
    Quincy
    Up with high volume, will wait for whether it can overtake the next resistance of $245 before selling covered calls.